Literature DB >> 11124439

Alzheimer disease is multifactorial and heterogeneous.

K Iqbal1, I Grundke-Iqbal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11124439     DOI： 10.1016/s0197-4580(00)00191-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  7 in total

1.  Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.

Authors:  Alessandra S Kiametis; Mônica A Silva; Luiz A S Romeiro; João B L Martins; Ricardo Gargano
Journal:  J Mol Model       Date:  2017-02-09       Impact factor: 1.810

2.  Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures.

Authors:  I Buendia; E Parada; E Navarro; R León; P Negredo; J Egea; M G López
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

3.  Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.

Authors:  Alireza Basiri; Michelle Xiao; Alec McCarthy; Debashis Dutta; Siddappa N Byrareddy; Martin Conda-Sheridan
Journal:  Bioorg Med Chem Lett       Date:  2016-11-24       Impact factor: 2.823

Review 4.  Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.

Authors:  Maria Laura Bolognesi; Andrea Cavalli; Carlo Melchiorre
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

5.  Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients.

Authors:  M Zamani; M Mehri; A Kollaee; P Yenki; M Ghaffarpor; M H Harirchian; M Shahbazi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-06-29

Review 6.  Recent developments of protein kinase inhibitors as potential AD therapeutics.

Authors:  Volkmar Tell; Andreas Hilgeroth
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

7.  Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

Authors:  Simona Capsoni; Sabina Giannotta; Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-30       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.